Nexalin Technology NXL 深 沪
交易中 08-31 11:37:11 美东时间
6.61
-0.890
-11.87%
华盛通- 最 高7.13
- 今 开6.28
- 成交量 1.09万股
- 最 低 6.25
- 昨 收 7.50
- 总市值 1.70亿
- 52周最高 7.13
- 市盈率 静 --
- 换手率 0.04%
- 52周最低 0.2201
- 委 比 14.16%
- 总股本 2566.54万
- 历史最高 7.13
- 量 比 0.10
- 振 幅 11.73%
- 历史最低 0.2201
- 每 手 1
- 风险率 0.35%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Nexalin Technology shares are trading lower after the company announced a 1-for-30 reverse stock split.
Nexalin Technology shares are trading lower after the company announced a 1-for-30 reverse stock split.
08-28 00:53
Nexalin Announces 1-for-30 Reverse Stock Split Approval
Nexalin Technology, Inc. ( ($NXL) ) has provided an update. Nexalin Technology,...
08-27 19:59
Nexalin Technology Announces Reverse Stock Split
Nexalin Technology, Inc. (Nasdaq: NXL) has approved a 1-for-30 reverse stock split to maintain compliance with Nasdaq's bid-price rule. The split will take effect on August 28, 2026, with shares trading under the new CUSIP number on August 31. Each 30 shares will combine into one, with no change to the $0.001 par value. Fractional shares will result in cash payments. The company's neurostimulation products aim to address mental health disorders, ...
08-27 11:25
Nexalin Technology Raises Liquidity via Short-Term Note
An update from Nexalin Technology, Inc. ( ($NXL) ) is now available. On August ...
08-22 06:01
Nexalin Announces Capital Raise and Flexible Equity Facility
Nexalin Technology, Inc. ( ($NXL) ) has provided an announcement. On August 19,...
08-21 05:59
Nexalin Faces New Nasdaq Equity Deficiency, Delisting Risk
Nexalin Technology, Inc. ( ($NXL) ) has issued an update. On August 14, 2026, N...
08-17 21:54
Nexalin Expands and Extends Houston Headquarters Lease Commitment
Nexalin Technology, Inc. ( ($NXL) ) has shared an announcement. On July 28, 202...
07-30 05:49
Nexalin Appeals Nasdaq Delisting Following Compliance Shortfalls
An announcement from Nexalin Technology, Inc. ( ($NXL) ) is now available. On J...
07-28 05:50
Nexalin Overhauls Bylaws, Modernizes Corporate Governance Framework
The latest announcement is out from Nexalin Technology, Inc. ( ($NXL) ). On Jun...
06-18 06:57
Nexalin Technology To Present Clinical Data Showing 77.8% Anxiety Response Rate, Durable 8-Week Benefits, And No Serious Adverse Events From Its 15 mA, 77.5 Hz DIFS Deep-Brain Stimulation Platform, At 2026 NYC Neuromodulation Conference
Accepted abstracts showcase Nexalin's proprietary DIFS™ 15 mA 77.5 Hz treatment platform and clinical improvements across anxiety, depression, insomnia and quality of life Data to be presented include 77.8% anxiety response rate at end of treatment, durable benefits maintained at 8-week follow-up an...
06-16 21:18
